| A comprehensive review of sources of nitrosamine contamination of pharmaceutical substances and products H Akkaraju, R Tatia, SS Mane, AB Khade, SJ Dengale Regulatory Toxicology and Pharmacology 139, 105355, 2023 | 19 | 2023 |
| Development of posaconazole nanosuspension for bioavailability enhancement: Formulation optimization, in vitro characterization, and pharmacokinetic study T Kolipaka, S Sen, SS Mane, GD Bajad, SJ Dengale, OP Ranjan Journal of Drug Delivery Science and Technology 83, 104434, 2023 | 8 | 2023 |
| Development and validation of LC-MS/MS method for estimating the pharmacokinetics, protein binding, and metabolic stability of soluble epoxide hydrolase inhibitor EC5026 R Biradar, S Dey, SS Mane, SJ Dengale Journal of Pharmaceutical and Biomedical Analysis 237, 115797, 2024 | 1 | 2024 |
| In vitro, in-vivo, and in-silico investigation of physicochemical interactions between pioglitazone and rifampicin O Londhe, SS Mane, BU Hirlekar, A Subbevarapu, AE Viju, VA Dixit, ... European Journal of Pharmaceutics and Biopharmaceutics 188, 54-65, 2023 | 1 | 2023 |
| Identification and characterization of the in-vivo metabolites of the novel soluble epoxide hydrolase inhibitor EC5026 using liquid chromatography quadrupole time of flight … S Dey, R Biradar, SS Mane, AK Shaji, AP Das, SM Agarwal, SJ Dengale Journal of Pharmaceutical and Biomedical Analysis 244, 116116, 2024 | | 2024 |
